Health care industry
Trump Warns: Pharma Tariffs Could Soar to 250%—What This Means for You
President Donald Trump recently discussed potential tariffs on imported pharmaceuticals during an interview with CNBC. He mentioned that these tariffs ... Read more
Pfizer Boosts 2025 Profit Forecast: Discover How Cost Cuts and Stellar Quarterly Results Drive Growth
Pfizer recently raised its profit outlook for the year, pointing to strong performance and successful cost-cutting measures. The company now ... Read more
Hims & Hers Shares Drop 10% After Revenue Miss: What Investors Need to Know
Shares of Hims & Hers Health dropped 9% after the company revealed second-quarter results that fell short of Wall Street’s ... Read more
Moderna Adjusts 2025 Revenue Forecast Due to UK Vaccine Shipment Delays: What It Means for Investors
Moderna recently adjusted its revenue forecast for 2025, lowering expectations due to delays in vaccine shipments to the U.K. Even ... Read more
UnitedHealth’s Disappointing Q2 Results and Dim 2025 Outlook: What It Means for Investors
UnitedHealth recently reported disappointing earnings for the second quarter of the year, causing its stock price to drop. The health ... Read more
UnitedHealth Predicts Lower 2025 Earnings Amid Rising Medical Costs: What It Means for Insurers
UnitedHealth Group recently shared its outlook for 2025, and the news isn’t great. The company anticipates adjusted earnings of at ... Read more
UnitedHealth Collaborates with DOJ on Medicare Billing Practices Investigation: What You Need to Know
UnitedHealth Group is currently under investigation by the Justice Department regarding its Medicare billing practices. This comes as a significant ... Read more
3 Democrat-Led States Tighten Medicaid Access for Undocumented Residents: What You Need to Know
In California, many immigrants have relied on family for health advice, primarily out of fear of seeking medical help due ... Read more
How 3 Democrat-Led States Are Changing Medicaid Access for Those Without Permanent Legal Status
Maria had been managing her asthma and her husband’s diabetes for nearly two decades without proper medical support. Living in ... Read more
Sarepta Therapeutics Faces 40% Stock Drop: What This Means for the Future of Gene Therapy
Shares of Sarepta Therapeutics tumbled over 30% recently, raising concerns about the future of its gene therapy treatment, Elevidys. The ... Read more
